SYNLAB AG
Moosacher Strasse 88
Munich 80809
Germany
49 89 307602 0
https://www.synlab.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 22,000
高階主管
| 名稱 | 標題 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Mathieu Floreani | Chief Exec. Officer | 無 | 無 | 1968 |
| Dr. Bartholomäus Wimmer | Founder & Member of the Supervisory Board | 無 | 無 | 1961 |
| Mr. Sami Badarani | Chief Financial Officer | 無 | 無 | 1963 |
| Mr. Robert Steinwander | Chief Operating Officer | 無 | 無 | 無 |
| Mr. Luis Vieira | Chief Scientific Officer | 無 | 無 | 無 |
| Mr. Henrik Andreasen | Chief Information Officer | 無 | 無 | 無 |
| Ms. Catharina Monster | Chief HR Officer | 無 | 無 | 無 |
| Dr. Santiago Valor | Chief Medical Officer | 無 | 無 | 無 |
截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。
描述
SYNLAB AG provides clinical laboratory and medical diagnostic services for practicing doctors, clinics, patients, and the pharmaceutical industry primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 450 laboratories and 1,600 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
公司管治
截至 無 止，SYNLAB AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
